{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:21:12Z","timestamp":1787498472117,"version":"build-2736575974"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Monoclonal gammopathy of renal significance (MGRS) represents a group of disorders caused by monoclonal immunoglobulin (M protein) secreted by B cells or plasma cells. Proliferative glomerulonephritis with monoclonal immunoglobulin deposition (PGNMID) is a glomerular disease and a form of MGRS. Here, we presented a rare case of a patient with IgM kappa PGNMID complicated with nocardiosis dermatitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns and diagnoses<\/jats:title>\n                    <jats:p>A 56-year-old man was admitted to the hospital because of cutaneous purpura and proteinuria. His initial pathological diagnosis indicated membranous proliferative glomerulonephritis, IgM(++), and subacute interstitial nephritis. Based on further examination, he was finally diagnosed to have IgM kappa PGNMID and subacute interstitial nephritis. After the initial diagnosis, the patient received hormonal therapy. During the treatment, nocardiosis dermatitis emerged as a complication, and the hormonal therapy was gradually reduced. The patient refused further treatment with rituximab, and his health is currently stable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>IgM kappa PGNMID complicated with nocardiosis dermatitis is an extremely rare occurrence. Laboratory examination and pathological analysis are required to confirm the diagnosis of this disorder. Timely and accurate diagnosis is essential for the appropriate treatment of PGNMID.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2024.1161560","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:12:46Z","timestamp":1712880766000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["IgM kappa proliferative glomerulonephritis with monoclonal immunoglobulin deposition complicated with nocardiosis dermatitis: a case report and review of literature"],"prefix":"10.3389","volume":"11","author":[{"given":"Kebao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1681\/ASN.2017121319","article-title":"The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases","volume":"29","author":"Sethi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/ckj\/sfab269","article-title":"An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits","volume":"15","author":"Li","year":"2022","journal-title":"Clin Kidney J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1523-1755.2004.00365.x","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis","volume":"65","author":"Nasr","year":"2004","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s13730-021-00653-3","article-title":"A case of proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) that responded favorably to steroid therapy","volume":"11","author":"Ogura","year":"2022","journal-title":"CEN Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.2147\/IJGM.S386733","article-title":"A review on the diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits","volume":"15","author":"Lin","year":"2022","journal-title":"Int J Gen Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.ekir.2022.07.009","article-title":"Efficacy of immunomodulatory drugs in combination with dexamethasone in proliferative glomerulonephritis with monoclonal immunoglobulin deposits","volume":"7","author":"Zhou","year":"2022","journal-title":"Kidney Int Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0161-5890(01)00025-6","article-title":"Role of natural and immune IgM antibodies in immune responses","volume":"37","author":"Boes","year":"2000","journal-title":"Mol Immunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2901","article-title":"The double life of a B-1 cell: self-reactivity selects for protective effector functions","volume":"11","author":"Baumgarth","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"12776","DOI":"10.3390\/ijms222312776","article-title":"3D structures of IgA, IgM, and components","volume":"22","author":"Pan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-3083.1975.tb02620.x","article-title":"IgM molecules with and without J chain in serum and after purification, studied by ultracentrifugation, electrophoresis, and electron microscopyn","volume":"4","author":"Eskeland","year":"1975","journal-title":"Scand J Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.aaz5425","article-title":"Structural insights into immunoglobulin M","volume":"367","author":"Li","year":"2020","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1007\/s10875-014-0022-7","article-title":"The long elusive IgM Fc receptor, Fc\u03bcR","volume":"34","author":"Kubagawa","year":"2014","journal-title":"J Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.7861\/clinmed.2023-RM3","article-title":"Monoclonal gammopathies of renal significance","volume":"23","author":"Gnanasampanthan","year":"2023","journal-title":"Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","article-title":"The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group","volume":"15","author":"Leung","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2215\/CJN.00560117","article-title":"Dysproteinemias and glomerular disease","volume":"13","author":"Leung","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1272\/jnms.JNMS.2019_86-1","article-title":"Monoclonal immunoglobulin deposition disease and related diseases","volume":"86","author":"Kanzaki","year":"2019","journal-title":"J Nippon Med Sch"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40620-020-00723-2","article-title":"Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary?: Two case reports and literature review","volume":"33","author":"van Kruijsdijk","year":"2020","journal-title":"J Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1053\/j.ajkd.2019.04.029","article-title":"Dysproteinemia and the kidney: core curriculum 2019","volume":"74","author":"Hogan","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.12998\/wjcc.v9.i10.2357","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits in a young woman: a case report","volume":"9","author":"Xu","year":"2021","journal-title":"World J Clin Cases"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ki.2013.548","article-title":"Membranous-like glomerulopathy with masked IgG kappa deposits","volume":"86","author":"Larsen","year":"2014","journal-title":"Kidney Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ekir.2016.08.012","article-title":"Clinicopathologic features of membranous-like glomerulopathy with masked IgG kappa deposits","volume":"1","author":"Larsen","year":"2016","journal-title":"Kidney Int Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/ki.2015.195","article-title":"Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits","volume":"88","author":"Larsen","year":"2015","journal-title":"Kidney Int"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.ekir.2018.07.008","article-title":"Paraffin immunofluorescence: a valuable ancillary technique in renal pathology","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MNH.0000000000000783","article-title":"Novel approaches beyond standard immunofluorescence for kidney biopsies","volume":"31","author":"Santoriello","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1123117","DOI":"10.3389\/fimmu.2022.1016263","article-title":"Rheumatoid factor IgM autoantibodies control IgG homeostasis","volume":"13","author":"Nicol\u00f2","year":"2022","journal-title":"Front Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/rheumatology\/keac593","article-title":"Genetic architecture underlying IgG-RF production is distinct from that of IgM-RF","volume":"62","author":"Yaku","year":"2023","journal-title":"Rheumatology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13730-017-0291-0","article-title":"A case report of proliferative glomerulonephritis with monoclonal immunoglobulin M-kappa deposits without associated lymphoproliferative disorder or detectable paraproteinemia","volume":"7","author":"Yamaguchi","year":"2018","journal-title":"CEN Case Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.ekir.2021.04.026","article-title":"A fresh perspective on monoclonal gammopathies of renal significance","volume":"6","author":"Aucouturier","year":"2021","journal-title":"Kidney Int Rep"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s40620-022-01317-w","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: an entity associated with distinct diseases and comparison between IgG1 and IgG3 subtypes","volume":"35","author":"Liu","year":"2022","journal-title":"J Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/ckj\/sft121","article-title":"Relapsing proliferative glomerulonephritis with monoclonal IgG deposits showing circumferential crescentic glomerulonephritis","volume":"6","author":"Oshio","year":"2013","journal-title":"Clin Kidney J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/j.humpath.2012.04.004","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin G3kappa deposits in association with parvovirus B19 infection","volume":"43","author":"Fujita","year":"2012","journal-title":"Hum Pathol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1590\/abd1806-4841.20163989","article-title":"Cutaneous involvement by cytomegalovirus in a renal transplant recipient as an indicator of severe systemic infection","volume":"91","author":"Neumann","year":"2016","journal-title":"An Bras Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07456.x","article-title":"Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients","volume":"155","author":"Choi","year":"2006","journal-title":"Br J Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"8728","DOI":"10.3390\/ijms22168728","article-title":"Immune prophylaxis and therapy for human cytomegalovirus infection","volume":"22","author":"Struble","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1399-3062.2009.00413.x","article-title":"Nocardia farcinica pericarditis after kidney transplantation despite prophylaxis","volume":"11","author":"Mcphee","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.mayocp.2011.11.016","article-title":"Nocardiosis: updates and clinical overview","volume":"87","author":"Wilson","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1473-3099(20)30920-8","article-title":"Treatment of disseminated nocardiosis: a host-pathogen approach with adjuvant interferon gamma","volume":"21","author":"Derungs","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ndt\/gfz176","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective","volume":"36","author":"Bridoux","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s40620-022-01332-x","article-title":"Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature","volume":"35","author":"Oki","year":"2022","journal-title":"J Nephrol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e225205","DOI":"10.1136\/bcr-2018-225205","article-title":"Successful management of proliferative glomerulonephritis with monoclonal immune deposits with combined immunosuppressive therapy","volume":"11","author":"Maan","year":"2018","journal-title":"BMJ Case Rep"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/nep.12775","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft","volume":"21","author":"Sawada","year":"2016","journal-title":"Nephrology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1681\/ASN.2020101541","article-title":"Safety and efficacy of daratumumab in patients with proliferative GN with monoclonal immunoglobulin deposits","volume":"32","author":"Zand","year":"2021","journal-title":"J Am Soc Nephrol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1161560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:12:49Z","timestamp":1712880769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1161560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":42,"alternative-id":["10.3389\/fmed.2024.1161560"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1161560","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]},"article-number":"1161560"}}